We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Brexit – What's next for Life Sciences companies?

3 April 2017 12:00 pm BST and 5 April 2017 4:00 pm BST

Join us for a webinar to learn more about the implications for the life sciences sector of the momentous decision that the UK has made to leave the EU.

We are expecting the UK Government to issue its Article 50 notice imminently.

The Life Sciences lawyers Charles Brasted, Elisabethann Wright, Fabien Roy, Helen Kimberley and Sahira Khwaja will discuss:

 

  • What is the likely process from the serving of the Article 50 notice to the UK leaving the EU?
  • What effect might Brexit have for existing and future marketing authorisations for medicinal products?
  • How might medical device manufacturers be affected?
  • How does the decision affect commercial contracts?
  • What are the questions you should consider from an IP perspective?
  • Is there anything you should do immediately?
  • How can your businesses influence what happens next?

 

We look forward to having you join us.

Click here to register




3 April 2017 12:00 pm BST and 5 April 2017 4:00 pm BST

From Hogan Lovells

Loading data